Navigation Links
Researchers make racehorses fertile
Date:2/14/2013

Ten percent of mares have difficulties conceiving. The most common cause of a mare's reduced fertility is a chronic infection in the mucusal membrane of the uterus caused by the bacteria 'Streptococcus equi subspecies zooepidemicus'.

"We noticed that many horses that test negative for streptococci have a dormant infection without showing clinical symptoms. Despite the lack of symptoms, however, it still seems to reduce the fertility of the mares," says Professor Anders Miki Bojesen, from the Department of Veterinary Disease Biology at the University of Copenhagen.

But he and veterinarian PhD Morten Rnn Petersen, who works at the Fertility Department at Copenhagen University Hospital, have found a solution to the problem. From their research, the two managed to activate the sleeping bacteria with an invention that they call Bactivate.

"Once you wake the bacteria you can diagnose the infection and treat the horses with regular antibiotics. Streptococci are usually not resistant to antibiotics, but during dormancy the metabolism is so low that antibiotics are rendered useless. Bactivate is made up of signalling components that rouse the bacteria and lead them to quickly start dividing and multiplying like normal and treatable streptococci," says Anders Miki Bojesen.

Fertility restored

Bactivate was tested at one of the world's largest horse hospitals, Hagyard Equine Medical Institute. The hospital is placed in Lexington, Kentucky, also known as 'the Horse Capital of the World'. The mares that received Bactivate developed substantial but treatable uterus infections.

"We tested on 64 breeding mares at Hagyard that had demonstrated a substantially reduced ability to conceive. Following treatment, 83 percent of the mares got pregnant within one and a half month and 72 percent gave birth to a live foal. This means that fertility levels basically were normalized in mares that previously had not conceived for several cycles, some for years. When dormant streptococci were activated, the mares were treated and bred in the following cycle," Morten Rnn Petersen says.

Hagyard veterinarian Kristina Lu described the discovery as "an important step forward".

"At the end of the day it's an important diagnostic tool because it makes the bacteria grow which means it will definitely play an important role in fertility treatments," she adds.

Facts: Exclusive customers

The high success rate proved so encouraging that the hospital now has taken on the role of selling Bactivate in the US, while the researchers new company, 'Bojesen & Petersen Biotech', will produce it. Bactivate is developed for an exclusive group of customers and will initially be sold to treat some of the world's most valuable thoroughbreds. The best race horses can earn millions of dollars in prize money for their owners who can earn even more by breeding them.

Bactivate needs to be approved by the Danish Medicines Agency before it can be sold in Denmark. Copenhagen Spin-Outs at University of Copenhagen is helping the scientists develop their business.


'/>"/>

Contact: Anders Miki Bojesen
miki@sund.ku.dk
45-23-84-41-88
University of Copenhagen
Source:Eurekalert  

Related biology news :

1. Study by UC Santa Barbara researchers suggests that bacteria communicate by touch
2. UC Santa Barbara researchers discover genetic link between visual pathways of hydras and humans
3. Researchers attempt to solve problems of antibiotic resistance and bee deaths in one
4. UNH researchers find African farmers need better climate change data to improve farming practices
5. Ottawa researchers to lead world-first clinical trial of stem cell therapy for septic shock
6. Researchers uncover molecular pathway through which common yeast becomes fungal pathogen
7. Researchers print live cells with a standard inkjet printer
8. Columbia Engineering and Penn researchers increase speed of single-molecule measurements
9. Researchers reveal how a single gene mutation leads to uncontrolled obesity
10. Researchers discover novel therapy for Crohns disease
11. New paper by Notre Dame researchers describes method for cleaning up nuclear waste
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Researchers make racehorses fertile
(Date:2/2/2016)... Feb. 2, 2016 Checkpoint Inhibitors for ... Market Are you interested in the future ... for checkpoint inhibitors. Visiongain,s report gives those predictions ... and national level. Avoid falling behind in ... opportunities and revenues those emerging cancer therapies can ...
(Date:2/1/2016)... -- Today, the first day of American Heart Month, the ... first of its kind workplace health solution that leverages ... first application of Watson to ... Welltok will create a new offering that combines AHA,s ... on Welltok,s health optimization platform. The effort is intended ...
(Date:1/25/2016)... , Jan. 25, 2016  Glencoe Software, the ... pharma and publication industries, will provide the data management ... Centre (NPSC). ... Phenotypic analysis measures ... whole organisms, allowing comparisons between states such as health ...
Breaking Biology News(10 mins):
(Date:2/10/2016)... , ... February 10, 2016 , ... ... the International Society of Pharmaceutical Engineering (ISPE) Rocky Mountain Chapter 21st Annual Vendor ... expecting to fill more than 100 tables for its annual event, which will ...
(Date:2/10/2016)... ... February 10, 2016 , ... PatientCrossroads announces ... the secure online PatientCrossroads platform, has exceeded both its one-year and overall recruitment ... PROMPT study, which seeks to advance understanding of the hereditary risks for certain ...
(Date:2/10/2016)... ... February 10, 2016 , ... Cenna Bioscience Inc., an ... treatment of Alzheimer’s disease, announced today it has been selected to present at the ... Breakers in Palm Beach, Florida. The purpose of the Forum is to help ...
(Date:2/9/2016)... 9, 2016  Regenicin, Inc. (OTC Bulletin Board: ... the development and commercialization of regenerative cell therapies ... organs, recently reported the Company,s operating results for ... 2016. Lonza America , Inc. (the ... year in the process of consummating an agreement ...
Breaking Biology Technology: